Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian clinical trials.

Donald A Berry1

  • 1Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 447, Houston, Texas 77030-4009, USA. dberry@mdanderson.org

Nature Reviews. Drug Discovery
|February 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2<sup>+</sup> breast cancer: TBCRC049 phase 2 study results.

Nature cancer·2026
Same author

Statistical innovations in clinical trial design with a focus on drug combinations, factorials, and other multiple therapy issues.

The journal of prevention of Alzheimer's disease·2025
Same author

Adaptive Bayesian Clinical Trials: The Past, Present, and Future of Clinical Research.

Journal of clinical medicine·2025
Same author

Annual Versus Biennial Mammographic Screening.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Bayesian clinical trials offer adaptive designs, enabling continuous data assessment and trial modification. This approach can lead to more efficient research and improved patient treatment outcomes.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Drug Development

Background:

  • Bayesian statistical methods are increasingly adopted in clinical research.
  • The Bayesian approach facilitates adaptation to accumulating trial data.

Purpose of the Study:

  • To explain the rationale behind Bayesian clinical trials.
  • To discuss their potential to enhance drug development effectiveness.

Main Methods:

  • Utilizing accumulating patient-outcome information and biomarkers.
  • Incorporating historical data and synthesizing results from relevant trials.
  • Allowing for continuous assessment and trial design modification.

Main Results:

  • Potential for smaller, more informative clinical trials.

Related Experiment Videos

  • Enables adaptive trial designs, including adjusting accrual and randomization.
  • Facilitates focus on responsive patient subsets and modification of treatment arms.

    • Conclusions:

    • Bayesian clinical trials offer a flexible and efficient framework.
    • They hold significant potential for improving drug development and patient care.